Position in ACAD
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$3,403,776
-$246,839 QoQ
Shares Held
152,910
+11.9% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Axecap Investments, LLC holds $3,403,776 across 1 Biotechnology name. ACAD ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
152,910 | $3,403,776 |
All Filings in ACAD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,403,776 | 152,910 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,650,615 | 136,676 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,339,937 | 203,371 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||